Empresa OKYO Pharma Limited London S.E.
Acciones
OKYO
GG00BMFG5F62
Farmacéuticos
Resumen de negocios
Número de empleados: 8
Directores
Directores | Puesto | Edad | Desde |
---|---|---|---|
Gary Jacob
CEO | Chief Executive Officer | 77 | 07/01/21 |
Keeren Shah
DFI | Director of Finance/CFO | 47 | 01/08/20 |
William Clementi
COO | Chief Operating Officer | - | 01/09/23 |
Raj Patil
CTO | Chief Tech/Sci/R&D Officer | 66 | 21/09/18 |
Paul Spencer
IRC | Investor Relations Contact | - | 01/12/22 |
Administradores
Administradores | Puesto | Edad | Desde |
---|---|---|---|
John Brancaccio
BRD | Director/Board Member | 76 | 10/06/20 |
Willy Simon
BRD | Director/Board Member | 72 | 01/06/15 |
Gabriele Cerrone
CHM | Chairman | 52 | 07/01/21 |
Gary Jacob
CEO | Chief Executive Officer | 77 | 07/01/21 |
Bernard Denoyer
BRD | Director/Board Member | 77 | 01/12/21 |
Clase de acciones
Vote | Quantity | Flotante | Autocontrol | Total Float | |
---|---|---|---|---|---|
Acción A | 1 | 25 519 882 | 186 793 ( 0,7320 %) | 0 | 42,63 % |
Acción B | 0 | 33 780 850 | 25 092 455 ( 74,28 %) | 0 |
Información de la empresa
![Dirección OKYO Pharma Limited(OKYO)](https://cdn.zonebourse.com/static/address/40601579.png)
Varia. 1 de ene. | Capi. | |
---|---|---|
+2,52 % | 92,1 mil M | |
-3,16 % | 37,92 mil M | |
-12,49 % | 32,97 mil M | |
+73,76 % | 27,92 mil M | |
-11,82 % | 16,14 mil M | |
-0,16 % | 14,1 mil M | |
-11,18 % | 11,66 mil M | |
+171,57 % | 10,29 mil M | |
-50,45 % | 9989,24 M |